Author:
Oliveira Suilane Coelho Ribeiro,Moniz Camila Motta Venchiarutti,Riechelmann Rachel,Alex Alexandra Kichfy,Braghirolli Maria Ignez,Bariani Giovanni,Nahas Caio,Hoff Paulo Marcelo Gehm
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology
Reference23 articles.
1. National Cancer Institute at the National Institutes of Health [Internet] [Place unknown][date unknown]. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/anal/HealthProfessional/page2
2. Patel H, Polanco-Echeverry G, Segditas S, et al. Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous carcinoma. Int J Cancer. 2007;121:2668–73.
3. Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann of Oncol. 2014;00:1–11.
4. UKCCR Anal Cancer Working party. Epidermoid anal cancer: results from the UKCCR randomized trial of radiotherapy alone versus radiotherapy, 5- fluorouracil and mitomycin. Lancet. 1996;348:1049–54.
5. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040–9.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献